New developments in the molecular pathology of human colon cancer: Relevance to pathogenesis and diagnosis

Advances in Anatomic Pathology

Volumn 3, Issue 6, 1996, Pages 343-350

  Jothy, Serge ^a   Flanders, Tamar Y ^a   Nowacki, Piotr M ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Colon cancer; Diagnosis; Molecular biology; Pathogenesis; Review

Indexed keywords

EID: 2042504297     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-199611000-00001     Document Type: Review

References (68)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
2. Su L-K, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993;262:1734-7.
3. Rubinfeld B, Souza B, Albert I, et al. Association of the APC gene product with beta-catenin. Science 1993;262:1731-4.
4. Eidelman S, Damsky CH, Wheelock J, Damjanov I. Expression of the cell-cell adhesion glycoprotein CAM 120-80 in normal human tissues and tumors. Am J Pathol 1989;135:101-10.
5. Fearon ER, Cho KR, Nigra JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990;247:49-56.
6. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965;121:439-62.
7. Beauchemin N, Benchimol S, Cournoyer D, Fuks A, Staunen C. Isolation and characterization of full length functional cDNA clones for human carcinoembryonic antigen (CEA). Mol Cell Biol 1987;7:3221-30.
8. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989;57:327-34.
9. Boucher D, Cournoyer D, Stanners CP, Fuks A. Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. Cancer Res 1985;49:847-52.
10. Jothy S, Yuan S, Shirota K. Transcription of carcinoembryonic antigen in normal colon and colon carcinoma: in situ hybridization study and implication for a new in vivo functional model. Am J Pathol 1993;143:250-7.
11. Jothy S, Munro SB, LeDuy L, McClure D, Blaschuk OW. Adhesion and anti-adhesion in cancer: what matters more? Cancer Metastasis Rev 1995;14:363-76.
12. Zhou H, Fuks A, Alcaraz G, Boiling TJ, Stanners CP. Hemophilic adhesion between Ig superfamily carcinoembryonic antigen molecules involves double reciprocal bonds. J Cell Biol 1993;122:951-60.
13. Gunthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
14. Heider KH, Hofmann M, Horst E, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993;120:227-33.
15. Wielenga VJM, Heider KH, Offerhaus GJA, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993;53:4754-6.
16. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989;56:1057-62.
17. Weber GF, Ashkar S, Glimcher HC. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996;271:509-12.
18. Hofmann N, Rudy W, Zoller M, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991;51:5292-7.
19. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Gunthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1993;124:71-82.
20. Terpe HJ, Storkel S, Zimmer U, et al. Expression of CD44 isoforms in renal cell tumors. Am J Pathol 1996;148:453-63.
21. Mulder JWR, Wielenga VJM. Polak MM, et al. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut 1995;36:76-80.
22. Kim HG, Yang XL, Rosada C, Hamilton SR, August JT. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p-53 gene mutation. Arch Biochem Biophys 1994;310:504-7.
23. Mulder J-WR, Kruyt PM, Sewnath M, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994;26:1470-2.
24. Koretz K, Moller P, Lehnert T, Hinz U, Otto HF, Herfarth C. Effect of CD44v6 on survival in colorectal carcinoma. Lancet 1995;345:327-8.
25. Finke LH, Terpe HJ, Zorb C, Haensch W, Schlag PM. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1995;345:583.
26. Bosman FT, Debruine A, Flohil C, Vanderwurff A, Tenkate J, Dinjens WWM. Epithelial-stromal interactions in colon cancer. Int J Dev Biol 1993;37:203-11.
27. Herrera L, Kakati S, Gibas L, Pietrzak E, Sandberg AA. Brief clinical report: Gardner syndrome in a man with interstitial deletion of 5q. Am J Med Genet 1986;25:473-6.
28. Bodmer WF, Bailey JC, Bodmer J, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614-6.
29. Solomon E, Voss R, Hall V, et al. Chromosome 5 allele loss in human colorectal carcinomas. Nature 1987;328:616-9.
30. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
31. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991;253:665-9.
32. Spirio L, Olschwang S, Groden J, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993;75:951-7.
33. Olschwang S, Tiret A, Laurentpuig P, Muleris M, Parc R, Thomas G. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis-coli patients. Cell 1993;75:959-68.
34. Warthin AS. Heredity with reference to carcinoma. Ann Intern Med 1913;12:546-55.
35. Lynch HT, Shaw MW, Magnosson CW, Larsen AL, Krush AJ. Hereditary factors in two large midwestern kindreds. Arch Intern Med 1966;117:206-12.
36. Lynch HT, Smyrk T, Watson P, et al. Hereditary colorectal cancer. Semin Oncol 1991;18:337-66.
37. Vasen HFA, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
38. Mecklin JP, Jarvinen HJ. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer 1991;68:1109-12.
39. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colon cancer. Cancer 1993;71:677-85.
40. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
41. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J. Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 1993;53:5100-3.
42. Weber JL, May PE. Abundant classes of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989;44:388-96.
43. Aaltonen LA, Peltomaki P, Mecklin JP, et al. Replication errors in benign and malignant tumors from hereditary non-polyposis colorectal cancer patients. Cancer Res 1994;54:1645-8.
44. Lothe RA, Peltomaki P, Meting GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993;53:5849-52.
45. Samowitz WS, Stattery ML, Kerber RA. Microsatellite instability in human colonic cancer is not a useful clinical indicator of familial colorectal cancer. Gastroenterology 1995;109:1765-71.
46. Borrasen AL, Lothe RA, Meling GI, et al. Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet 1995;4:2065-72.
47. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
48. Jacoby RF, Marshall DJ, Kailas S, Schlack S, Harms B, Love R. Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer. Gastroenterology 1995;109:73-82.
49. Markowitz S, Wang J, Meroff L, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-8.
50. Paraf F, Sasseville D, Watters AK, et al. Muir-Torre syndrome. Hum Pathol 1995;26:422-7.
51. Honchel R, Halling KC, Schaid DJ, Pittelkow M, Thibodeau SN. Microsatellite instability in Muir-Torre syndrome. Cancer Res 1994;54:1159-63.
52. Parsons R, Li GM, Longley MJ, et al. Hypermutability and mismatch repair deficiency in RER + tumor cells. Cell 1993;75:1227-36.
53. Fishel R, Lescoe MK, Rao MRS, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
54. Cleaver JE. It was a very good year for DNA repair. Cell 1994;76:1-4.
55. Peltomaki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810-2.
56. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
57. Umar A, Boyer JC, Thomas DC, et al. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem 1994;269:14,367-70.
58. Lindblom A, Tannergard P, Werelius B, Nordenskjold M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genet 1993;5:279-82.
59. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368:258-61.
60. Kolodner RD, Hall NR, Lipford J, et al. Structure of the human MLH1 locus and analysis of a large hereditary non-polyposis colorectal carcinoma kindred for MLH1 mutations. Cancer Res 1995;55:242-8.
61. Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a Mutl homologue in hereditary colon cancer. Science 1994;263:1625-9.
62. Smyrk TC. Colon cancer connections: cancer syndrome meets molecular biology meets histopathology. Am J Pathol 1994;145:1-6.
63. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
64. Koi M, Umar A, Chauhan DP, et al. Human chromosomes 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N″-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous AMLH1 mutation. Cancer Res 1994;54:4308-12.
65. Hamilton SR, Liu B, Parsons REE, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995;332:839-85.
66. Lowe S, Bodis S, McClatchey A, et al. p53 status and the efficacy of cancer therapy in vivo. Science 1994;266:807-10.
67. Goh H-S, Yao J, Smith DR. p53 point mutation and survival in colorectal cancer patients. Cancer Res 1995;55:5217-221.
68. Jass JR, Cottier DS, Jeevaratnam P, et al. Diagnostic use of microsatellite instability in hereditary nonpolyposis colorectal cancer. Lancet 1995;346:1200-1.